Immunologic recovery of patients given CD34-selected peripheral blood progenitor cell transplantation for malignant diseases
High-dose chemotherapy with or without total body irradiation and autologous peripheral blood progenitor cell transplantation (APBPCT) is an effective therapy for selected patients with neoplastic disease resulting in significant improvements of disease-free and overall survival.
1,2 Positive selection of peripheral blood progenitor cells (PBPC) for CD34-expressing cells permits 1 to 4 logs of tumor cell depletion. 3 Hematologic recovery after CD34 + cell transplantation has reportedly been rapid and similar to results achieved in unselected APBPCT. 3, 4 In vitro T cell depletion affects T cell regeneration and increases the risk of viral infections after allogeneic and autologous stem cell transplantation. 5, 6 To date, a limited amount of data on immune reconstitution after CD34
+ cell selection has been available. 7, 8 Recently, a delay in lymphoid reconstitution of both T cells and B cells has been observed in nine recipients of CD34 + selected PBPC compared to recipients of unseparated PBPC. 7 Here, we present results on immune reconstitution including assessment of infections in 58 consecutive patients given PBPC transplantations enriched for CD34 + cells at our institution. The 22 males and 36 females, aged 17 to 58 (median 43) years underwent high-dose therapy for lymphoma (n = 19), myeloma (n = 10) or breast cancer (n = 29). Thirty-one were cytomegalovirus (CMV) positive prior to APBPCT. A mean of 7.2 (range, 1.9-23.5) × 10 8 NC/kg b.w. were collected during a mean of 2.5 (range, 1-4) leukaphereses without any significant complications. After CD34 selection with an avidin-immunoaffinity column device (CEPRATE SC; Cell Pro, Bothell, WA, USA) as described, 3 the mean CD34 + recovery was 54.8% (range, 25.1-99.9%) with a 64.2-fold enrichment. Patients received a mean of 5.7 × 10 6 (range, 1.3-12.6) CD34 + cells/kg b.w. for transplantation. Hematologic regeneration was prompt with a rise of ANC Ͼ0.5 × 10 9 /l after a median of 11 (range, 9-25) days and platelet counts Ͼ20 × 10 9 /l, 50 × 10 9 /l, and 100 × 10 9 /l after a median of 14 (range, 7-34), 20 (range, 10-62) and 32 (11-120) days after transplantation. Within the first 30 days of APBPCT 26 (45%) patients had infections consisting of fever of unknown origin (n = 16), bacteremia (Streptococcus mitis, Staphylococcus epidermidis; n = 6), cystitis (n = 1), Candida albicans enteritis (n = 1) or stomatitis (n = 2) and lethal E. coli sepsis in one patient (Table 1) . One patient had two different infectious episodes. During follow-up more than 1 month after APBPCT all bacterial infections except one occurred in one lymphoma patient who relapsed on day +360 and died 450 days after transplantation. No clinically apparent CMV infections were observed. The comparison of infectious episodes performed by the Mann-Whitney U test revealed a significantly lower rate of bacterial infections within 30 days of APBPCT (P = 0.03) and viral infections longer than 30 days after transplan- 
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+ cells/l in the peripheral blood of 58 patients transplanted with CD34 + PBPC and assessed by FACS analysis 3, 6 and 12 months after transplantation. tation (P Ͻ 0.001) in breast cancer patients compared with lymphoma patients. Median follow-up is 20 months for lymphoma, 18 months for myeloma, and 23 months for breast cancer patients. To identify features unique to immune reconstitution after APBPCT, lymphoid phenotype and antibody production were assessed 3, 6 and 12 months after transplantation. Serum immunoglobulin levels were determined by nephelometry. At 3 months 17, at 6 months nine and at 12 months nine samples were available for flow cytometric analyses. (Figure 1 ). This is consistent with previously reported findings in recipients of unseparated PBPC. 9 B cell normalization in our study, however, was faster than reported by Bomberger et al 7 after CD34 + PBPCT. The CD3
+ T cells showed a delayed recovery with 776 cells/l (s.d.: Ϯ634) 3 months after transplantation. The values normalized after 6 months with 1097 cells/l (s.d.: Ϯ932) which compares favorably with findings after unseparated PBPCT 9 and is in contrast to observations by Bomberger et al. 7 There, however, even the control population given unseparated PBPC failed to recover a normal T cell count by 12 months after treatment. Inversion of the CD4/CD8 ratio of peripheral blood T cells was seen in all recipients of CD34 + grafts until 12 months after transplantation. The low CD4/CD8 ratio was mainly the result of very low numbers of CD4 + T cells. These were 191 (s.d.: Ϯ117)/l at 3 months, 192 (s.d.: Ϯ200)/l at 6 months, and 339 (s.d.: Ϯ167)/l at 12 months after APBPCT, respectively. In one patient no CD4
+ cells were detectable in the peripheral blood until 6 months. He died 251 days post transplant due to varicella zoster infection. Decreased CD4 + cell numbers have also been reported after unseparated PBPCT and could persist for a year or longer.
9,10 Despite prolonged T cell deficiency no increased incidence of opportunistic infections was seen within the observation period of our study. The incidence of varicella zoster virus infection was 9% in our study which compares favorably with previous reports. 11 In our preliminary analysis 12 cytomegalovirus reactivations which were observed in routine surveillance cultures were included. These patients and others included in this analysis in addition, however, did not experience clinical signs of infection despite lack of treatment. The mean number of circulating CD56 + NK cells reached the blood level of normal subjects during the first 3 months post transplant with mean values of 296 (s.d.: Ϯ405)/l which is in accordance with previous findings. 9, 10 Serum immunoglobulin levels normalized rapidly within the first 3 months after transplantation and remained normal during the study period.
In summary, transplantation of CD34-selected PBPC allows rapid and sustained hematologic engraftment. No marked delay of immune reconstitution compared with unseparated PBPC recipients was observed in our study. 
